Dose-response curves after in vivo experimental chemotherapy: Influence of rouze of administration on biological outcomes James V. Moore Editorial Pages: 91 - 92
The effect of cisplatin on renal ATPase activity in vivo and in vitro Jiro UozumiCharles L. Litterst Original Articles Pages: 93 - 96
Phase I study of the cisplatin analogue 1,1-diamminomethylcyclohexane sulfatoplatinum (TNO-6) (NSC 311056) J. B. SørensenS. GrothH. H. Hansen Original Articles Pages: 97 - 100
Kinetics of 7-hydroxy-methotrexate after high-dose methotrexate therapy R. ErttmannS. BielackG. Landbeck Original Articles Pages: 101 - 104
Differential calcium leucovorin protection of human lymphoid cell lines from methotrexate George P. BrowmanLynda BookerPaula Spiegl Original Articles Pages: 105 - 110
Comparison of leucovorin protection from variety of antifolates in human lymphoid cell lines George P. BrowmanPaula SpieglAndre Rosowsky Original Articles Pages: 111 - 114
Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate in rabbits Heiko IvenHelmut BraschJörg Engster Original Articles Pages: 115 - 120
Drug monitoring of etoposide (VP16-213) Harald DanigelKarl-Heinz PflügerJörg Dellbrügge Original Articles Pages: 121 - 124
Effects of amino acids on the transport and cytotoxicity of melphalan by human bone marrow cells and human tumor cells Maurice DufourLawrence C. PanasciLouise Boulet Original Articles Pages: 125 - 131
Pharmacokinetics and disposition of 4′-O-tetrahydropyranyladriamycin in mice by HPLC analysis Hiroshi IguchiHiroshi ToneHamao Umezawa Original Articles Pages: 132 - 140
The effects of arotinoids on rat mammary carcinogenesis Hans-Rudolf HartmannWerner Bollag Original Articles Pages: 141 - 143
A phase I and pharmacokinetic comparison of hepatic arterial and peripheral vein infusions of bisantrene for liver cancer Geoffrey R. WeissMarla HershThomas E. Pirtle III Original Articles Pages: 144 - 148
Pharmacokinetics of teniposide (VM 26) after IV administration in serum and malignant ascites of patients with ovarian carcinoma P. CanalR. BugatP. F. Combes Original Articles Pages: 149 - 152
Comparative murine metabolism and disposition of class II anthracycline antibiotics Pierre DodionMerrill J EgorinNicholas R. Bachur Original Articles Pages: 153 - 160
Doxifluridine (5′-dFUrd) in patients with advanced colorectal carcinoma Sophie D. FossåOlav DahlMitchell Loeb Original Articles Pages: 161 - 163
A phase II study of sequential methotrexate and fluorouracil in advanced colorectal cancer L. PanasciJ. FordR. Margolese Original Articles Pages: 164 - 166
Mechanism of adrenal suppression by high-dose medroxyprogesterone acetate in breast cancer patients H. van VeelenP. H. B. WillemseH. Doorenbos Original Articles Pages: 167 - 170
The treatment of postmenopausal women with advanced breast cancer with buserelin J. H. WaxmanS. J. HarlandT. A. Lister Original Articles Pages: 171 - 173
Nephrotoxicity of lomustine Mark E. EllisRaymond B. WeissMario Kuperminc Original Articles Pages: 174 - 175
High-performance liquid chromatographic assay for simultaneous estimation of aminoglutethimide and acethylamidoglutethimide in biological fluids Adam M. AdamIan D. BradbrookHoward J. Rogers Short Communication Pages: 176 - 178
Cisplatin, adriamycin and cyclophosphamide (PACe) combination chemotherapy in patients with ovarian carcinoma resistant to chlorambucil Graham M. MeadChristopher J. WilliamsJ. Michael Whitehouse Short Communication Pages: 179 - 180
Phase II study of a combination of mitomycin, doxorubicin and cisplatin in advanced sarcomas John H. EdmonsonHarry J. LongStephanie J. Green Short Communication Pages: 181 - 182
Concerning the paper Clinical pharmacology of high-dose cisplatin by Corden et al. Michael W. DeGregorioJordan R. WilburBrian J. Corden Letter to the Editor Pages: 183 - 184
